SEC Form 4 · accession 0000914190-15-000397
Cardiovascular Systems Inc · CSII
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
David Martin
Officer — President and CEO · Director
Period of report
Aug 27, 2015
Accepted (ET)
Aug 31, 2015 · 4:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001180145
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 27, 2015 | D | 20,696 | $0.00 | D | 478,464 | D | |
| Common Stock | holding | — | — | — | 850 | I | By child | |
| Common Stock | holding | — | — | — | 350 | I | By child | |
| Common Stock | holding | — | — | — | 850 | I | By child |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $7.90 | holding | — | — | — | — | Jun 11, 2017 | Common Stock | 90,580 | 90,580 | D |
| Stock Option (right to buy)F2 | $12.15 | holding | — | — | — | — | Dec 11, 2017 | Common Stock | 234,395 | 234,395 | D |
| Stock Option (right to buy)F2 | $8.75 | holding | — | — | — | — | Mar 1, 2019 | Common Stock | 32,350 | 32,350 | D |
Explanation of responses
- F1Represents shares of restricted stock granted in August 2014 that have been forfeited based on performance achieved for total shareholder return and annual revenue growth for fiscal 2015 versus the Company's peer group.
- F2Fully exercisable.